Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.3 Million AUD | -18.49% |
| 2022 | -8.69 Million AUD | -54.86% |
| 2021 | -5.61 Million AUD | -12.39% |
| 2020 | -4.99 Million AUD | -52.28% |
| 2019 | -3.28 Million AUD | 59.58% |
| 2018 | -8.11 Million AUD | -22.04% |
| 2017 | -6.65 Million AUD | -1.73% |
| 2016 | -6.53 Million AUD | -64.72% |
| 2015 | -3.96 Million AUD | -74.74% |
| 2014 | -2.27 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - AUD | -18.49% |
| 2023 Q2 | -3.32 Million AUD | 0.0% |
| 2023 Q1 | -3.32 Million AUD | -70.97% |
| 2023 Q4 | -1.96 Million AUD | 0.0% |
| 2023 Q3 | -1.96 Million AUD | 40.96% |
| 2022 Q4 | -1.94 Million AUD | -3.95% |
| 2022 FY | - AUD | -54.86% |
| 2022 Q3 | -1.86 Million AUD | 27.56% |
| 2022 Q2 | -2.57 Million AUD | -0.0% |
| 2022 Q1 | -2.57 Million AUD | -14.38% |
| 2021 Q3 | -2.23 Million AUD | -255.97% |
| 2021 Q4 | -2.25 Million AUD | -0.98% |
| 2021 FY | - AUD | -12.39% |
| 2021 Q2 | -627.4 Thousand AUD | 0.0% |
| 2021 Q1 | -627.4 Thousand AUD | 64.47% |
| 2020 Q1 | -708.52 Thousand AUD | 50.44% |
| 2020 Q2 | -708.52 Thousand AUD | 0.0% |
| 2020 Q4 | -1.76 Million AUD | -2.34% |
| 2020 FY | - AUD | -52.28% |
| 2020 Q3 | -1.72 Million AUD | -143.49% |
| 2019 Q1 | -182.49 Thousand AUD | 93.03% |
| 2019 FY | - AUD | 59.58% |
| 2019 Q3 | -1.4 Million AUD | -670.37% |
| 2019 Q2 | -182.49 Thousand AUD | 0.0% |
| 2019 Q4 | -1.42 Million AUD | -1.7% |
| 2018 Q2 | -1.66 Million AUD | 0.0% |
| 2018 FY | - AUD | -22.04% |
| 2018 Q3 | -2.62 Million AUD | -57.37% |
| 2018 Q1 | -1.66 Million AUD | 31.95% |
| 2018 Q4 | -2.61 Million AUD | 0.07% |
| 2017 FY | - AUD | -1.73% |
| 2017 Q3 | -2.44 Million AUD | -178.19% |
| 2017 Q4 | -2.44 Million AUD | 0.0% |
| 2017 Q2 | -879.45 Thousand AUD | 0.0% |
| 2017 Q1 | -879.45 Thousand AUD | 0.0% |
| 2016 FY | - AUD | -64.72% |
| 2015 FY | - AUD | -74.74% |
| 2014 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -786.068% |
| Arrayit Corporation | -3.07 Million USD | -234.849% |
| Atlantic International Corp. | -5.38 Million USD | -91.202% |
| Biocept, Inc. | -30.24 Million USD | 65.924% |
| Bioqual, Inc. | 3.03 Million USD | 439.847% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -1260.617% |
| DermTech, Inc. | -97.89 Million USD | 89.473% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.354% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 49.092% |
| iMD Companies, Inc. | -154.65 Thousand USD | -6563.027% |
| IDenta Corp. | 71.58 Thousand USD | 14495.031% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 368.568% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 26734.714% |
| InVitro International | 6680.00 USD | 154366.033% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -89.569% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -84826.413% |
| Medical Imaging Corp. | -896.74 Thousand USD | -1049.157% |
| NovelStem International Corp. | -3.78 Million USD | -172.201% |
| Optigenex Inc. | -1.18 Million USD | -768.354% |
| PharmChem, Inc. | 1.05 Million USD | 1077.878% |
| Proteome Sciences plc | -1.13 Million USD | -806.33% |
| Response Genetics, Inc | -19.66 Million USD | 47.6% |
| Rennova Health, Inc. | -234.81 Thousand USD | -4288.549% |
| RushNet, Inc. | -614.85 Thousand USD | -1576.008% |
| ScreenPro Security Inc. | -3.43 Million USD | -200.009% |
| Stella Diagnostics Inc. | -5.7 Million USD | -80.554% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -0.339% |
| Todos Medical Ltd. | -9.39 Million USD | -9.697% |